![](https://elevationoncology.com/wp-content/uploads/2020/09/Screen-Shot-2020-10-16-at-5.59.17-PM-1024x568.png)
Trial in Progress Virtual Poster Presentation
CRESTONE – Clinical Study of REsponse to Seribantumab in TumOrs with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)
Presenting Author: David Spigel, MD; Sarah Cannon Research Institute